Plea To FDA From Those Injured By COVID-19 Vaccines: 'Please Hear Us'
Executive Summary
Individuals who developed symptoms similar to long COVID after vaccination say their injuries are being ignored. Speaking at the agency’s VRBPAC meeting, they note the need for research and compensation for these injuries. To date, no COVID-19 vaccine injury claims have been reimbursed under federal compensation programs.
You may also be interested in...
Vaccines For Uninsured Adults Initiative Proposed In Biden’s Federal Budget For 2023
Biden budget proposal also addresses consolidating all Medicare coverage for vaccines under Part B, providing Medicare and Medicaid 'explicit' authority to cover vaccines approved under emergency use authorizations without cost sharing, and increasing 340B spending on program oversight.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.